PanTheryx And Dr. Reddy's Laboratories Ltd.’s Announce An Agreement To Market Pantheryx’s Proprietary Nutritional Intervention For Pediatric Infectious Diarrhea

BOULDER, Colo. & HYDERABAD, India--(BUSINESS WIRE)--PanTheryx, Inc., a global medical nutrition company based in Boulder, Colorado, and Dr. Reddy’s Laboratories Ltd. (NYSE: RDY), a leading global pharmaceutical company, announced today a multi-country supply and licensing agreement. The agreement grants Dr. Reddy’s the exclusive right to market and distribute PanTheryx’s breakthrough nutritional intervention, DiaResQ®, for infectious diarrhea in India and Nepal and in process for Russia, Myanmar, Vietnam, Ukraine, Sri Lanka, Kazakhstan, Belarus, Jamaica, and select LATAM markets. Dr. Reddy’s will market the product in India and Nepal under the “Reliqua™” brand.

Help employers find you! Check out all the jobs and post your resume.